IsoTherapeutics Group is a radiopharmaceutical development company that launched R&D services in 2005 to aid customers and collaborators in the development of pharmaceuticals. The company has earned a solid reputation in radiochemistry, radiolabeling, and process/product development. IsoTherapeutics Group has recently enhanced its capabilities to help customers with cGMP radiopharmaceutical manufacturing for clinical trials. This helps ensure seamless development of products from research to clinical trial-stage manufacturing.
IsoTherapeutics offers host of services to the pharmaceutical and life-science industries. The company specializes in R&D of radiopharmaceuticals that are targeted at detecting and treating debilitating diseases. The range of services include helping customers/partners with early stage research from proof of concept for a new chemistry or drug molecule through making of the drug in a cGMP facility for preclinical studies.
These services include:
The company also plays an advisory role based on its 100+ years of collective experience. The company works with customers in a variety ways and engages with customers every step of the way with the final goal being reduction of costs and shortening of the time to clinical trial.
CLIENTS / PARTNERS
In the company’s short history, IsoTherapeutics has been able to serve a variety of customers including: